News - Regulation, Global


Current filters:


Popular Filters

1 to 25 of 37 results

Lucrative biosimilars space to erode biologics market from 2019

Lucrative biosimilars space to erode biologics market from 2019


The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market…

BiosimilarsBiotechnologyGlobalMarkets & MarketingRegulation

European generics group welcomes WHA resolution on biotherapeutics products


The European Generic Medicines Association (EGA) has welcomed the 67th World Health Assembly’s Resolution…


EGA calls for international regulatory cooperation


European Generics Medicines Association (EGA) Director General Adrian van den Hoven last week joined…

GenericsGlobalPharmaceutical industryRegulationResearch

Global Fund taps pharmaceutical expertise in China


The Global Fund is deepening its partnership with China by tapping the expertise of Chinese pharmaceutical…

Anti-viralsAntibiotics and Infectious diseasesChinaGlobalMarkets & MarketingPharmaceuticalProductionRegulation

IFPMA and the Global Fund collaborate to help protect patients from fake medicines


The International Federation of Pharmaceutical Manufacturers and Associations and the Global Fund to…

Anti-viralsAntibiotics and Infectious diseasesGlobalMarkets & MarketingPharmaceuticalRegulationTropical diseases

Three big predictions for the global health care market


Three big predictions for the global health care market have been released by market research firm Frost…

GlobalMarkets & MarketingPharmaceuticalRegulation

Newly accessible Japanese encephalitis vaccine will make saving children easier in developing countries


A newly accessible vaccine against Japanese encephalitis which will make the protection of more children…

China National BiotecGlobalPharmaceuticalRegulationVaccines

WHO implements fee changes to its Prequalification of Medicines Program


Fee changes have come into force in the World Health Organization Prequalification of Medicines Program…


US FDA fast-tracks Elan's Alzheimer's drug candidate


Ireland-based Elan Corp (NYSE: ELN) says that the US Food and Drug Administration has granted Fast Track…

ElanELND005GlobalMarkets & MarketingNeurologicalNorth AmericaPharmaceuticalRegulation

EU falsified medicines directive: imported active substances need written confirmation to guarantee GMP standards


From July 2, 2013, all active substances manufactured outside of the European Union and imported into…


Pace of drug approvals to moderate for global pharma companies, says Fitch Ratings


Global pharmaceutical novel drug approvals will moderate in 2013 due to the exceptional research success…

BiotechnologyGlobalNorth AmericaPharmaceuticalRegulationResearch

Launching new drugs in the Outcome Era; report


The pharmaceutical industry is facing the Outcome Era. Launching a novel drug today obliges companies…

GlobalMarkets & MarketingPharmaceuticalPricingRegulation

Europe falling behind USA and China as attractive for life sciences sector


Intellectual property specialists Marks & Clerk's latest Life Sciences Report unveils the changing landscape…


Support for introduction of a global regulatory process for biosimilars


The majority of surveyed US and European physicians and payers are in favor of the introduction of a…


EMA reports on patient recruitment and geographical location of clinical trials


Almost 62% of the patients in pivotal trials submitted in marketing-authorisation applications (MAAs)…


INTERPOL and Pharma launch global initiative to combat fake medicines


Combating the global scourge of fake medicines, which threatens the health of millions of people, is…

GlobalMarkets & MarketingPharmaceuticalRegulation

OECD urges harmonization of clinical trial regulations to boost medical R&D


Increasingly complex and inconsistent clinical trial regulations are causing delays, raising costs and…


Sales of antiretroviral agents for HIV will decline slightly over next decade


Major-market sales of antiretroviral (ARV) agents for HIV will decline slightly over the next decade,…

Anti-viralsBiotechnologydolutegravirGenericsGlaxoSmithKlineGlobalMarkets & MarketingPharmaceuticalRegulationViiV Healthcare

Zeltia's Yondelis approved for sale in 10 new countries


Pharma Mar, a subsidiary of Spain's Grupo Zeltia (ZEL: MC), says it has been advised by its licensee…

GlobalJanssenJohnson & JohnsonOncologyPharmaceuticalPharmaMarRegulationYondelisZeltia

Novo Nordisk's Ryzodeg passes regulatory hurdle in Japan; diabetes burden review


Global insulin market leader Novo Nordisk (NOV: N) of Denmark revealed this morning that its Ryzodeg…

Asia-PacificDegludecDiabetesGlobalHealthcareNovo NordiskPharmaceuticalPricingRegulationRyzodegTresiba

A blip or stark reality? Pharma companies re-evaluate emerging markets


Pharmaceutical companies, which have previously been allaying the growing fears and concerns of their…

FinancialGlobalMarkets & MarketingPharmaceuticalPricingRegulation

1 to 25 of 37 results

Company Spotlight

Eleven Biotherapeutics

Eleven Biotherapeutics

Back to top